Stelac Advisory Services’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,520
| Closed | -$121K | – | 105 |
|
|
2025
Q1 | $121K | Hold |
5,520
| – | – | 0.05% | 92 |
|
|
2024
Q4 | $176K | Hold |
5,520
| – | – | 0.07% | 83 |
|
|
2024
Q3 | $159K | Hold |
5,520
| – | – | 0.06% | 88 |
|
|
2024
Q2 | $212K | Hold |
5,520
| – | – | 0.09% | 77 |
|
|
2024
Q1 | $324K | Hold |
5,520
| – | – | 0.15% | 59 |
|
|
2023
Q4 | $330K | Hold |
5,520
| – | – | 0.18% | 57 |
|
|
2023
Q3 | $210K | Hold |
5,520
| – | – | 0.11% | 77 |
|
|
2023
Q2 | $503K | Hold |
5,520
| – | – | 0.22% | 87 |
|
|
2023
Q1 | $364K | Hold |
5,520
| – | – | 0.16% | 101 |
|
|
2022
Q4 | $285K | Buy |
+5,520
| New | +$285K | 0.13% | 116 |
|